Does attachment change during Group Schema Therapy? Exploring attachment transformation during Time-Limited Schema-Focused Group Therapy with patients with personality disorder

This study aims to explore the relationship between interpersonal attachment across different significant others, therapy outcome and quality of life, among adults with personality disorders, during a Time-Limited Schema Focused Group Therapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN93941820

Enrollment

Registered

2024-11-11

Start date

2024-01-01

Completion date

Unknown

Last updated

2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of patients with personality disorder Mental and Behavioural Disorders

Interventions

Current interventions as of 15/09/2025: Participants were patients attending G-kracht with a referral from their general practitioner. Patients were referred to either a cognitive or experiential time

American Psychiatric Association, 2013) based on a clinical interview with their treating psychologist. Previous interventions: Participants were patients attending G-kracht with a referral from thei

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 15/09/2025: Participants were patients attending G-kracht with a referral from their general practitioner. Patients were referred to either a cognitive or experiential time-limited schema group therapy based on the experiences and opinions of several experienced clinicians. Previous inclusion criteria: Participants were patients attending G-kracht with a referral from their general practitioner. Patients were referred to either a cognitive or experiential short-term schema group therapy based on the experiences and opinions of several experienced clinicians.

Exclusion criteria

Exclusion criteria: 1. Diagnosis of Mental Retardation or a Pervasive Developmental Disorder 2. Acute risk of suicide 3. Too little empathic ability to participate in group therapy

Design outcomes

Primary

Measure	Time frame
Participants completed questionnaires at Time 1 (T0; before start), Time 2 (T1; 8 weeks later following completion of day 8) and Time 3 (T2; at the end of therapy). These questionnaires were part of the routine outcome measurement and results were discussed with the patients as part of their treatment. All assessments were administered by computer. 1. Attachment is measured by ECR-DS at T0, T1 and T2 2. The effect of therapy is predict a is measured by SQ-48 and WHO-5 at T0, T1, T2	—

Measure

Time frame

Participants completed questionnaires at Time 1 (T0; before start), Time 2 (T1; 8 weeks later following completion of day 8) and Time 3 (T2; at the end of therapy). These questionnaires were part of the routine outcome measurement and results were discussed with the patients as part of their treatment. All assessments were administered by computer. 1. Attachment is measured by ECR-DS at T0, T1 and T2 2. The effect of therapy is predict a is measured by SQ-48 and WHO-5 at T0, T1, T2

—

Secondary

Measure	Time frame
1. In order to explore if attachment differs between significant others, we will use the ECR-DS measured across three points (T0, T1, T2) 2. In order to explore the relationship between attachment anxiety and attachment avoidance to the therapist, we will use the ECR-DS at T1 and T2 and the treatment outcome measured at T2 in comparison with T0, with the SQ-48 questionnaire	—

Countries

Netherlands

Contacts

Public ContactNina Roosen

nina@splinter.care+31-158200240

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026